Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Gilead Sciences Inc (GILD)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,121.00 0.00    0.00%
29/04 - Closed. Currency in MXN ( Disclaimer )
  • Volume: 0
  • Bid/Ask: 1,030.02 / 1,161.00
  • Day's Range: 1,121.00 - 1,141.00
Type:  Equity
Market:  Mexico
ISIN:  US3755581036 
S/N:  375558103
Gilead 1,121.00 0.00 0.00%

GILD Recent Sentiments

 
User's sentiments regarding Gilead shares are displayed on both charts showing different time periods and in a detailed table.

Assess users' predictions on whether they expect GILD shares to be bearish or bullish and add your investment views to the bearish or bullish futures discussion for Gilead.
Start Date Username Call Open Rate End Date Chg. %
Nov 01, 2023 Zaid Nahle   1440.00 Nov 30, 2023 @ 1293.03 -10.21%
Dec 06, 2022 Mario Escamilla   1712.51 Dec 06, 2022 @ 1731.00 +1.08%
Feb 18, 2021 Marcelo Elizondo   1310.00 Mar 12, 2021 @ 1298.99 +0.84%
Nov 13, 2020 Allex Sainz   1244.00 Nov 13, 2020 @ 1244.00 0.00%
Oct 16, 2020 Ana Maria Ortega...   1300.00 Nov 06, 2020 @ 1239.00 +4.69%
Oct 13, 2020 Rul Lara   1346.00 Nov 06, 2020 @ 1239.00 +7.95%
Sep 28, 2020 Pio Quiroz   1416.00 Oct 23, 2020 @ 1274.65 -9.98%
Sep 04, 2020 brent goditiabois   1440.00 Sep 25, 2020 @ 1392.60 -3.29%
Aug 24, 2020 Ana Maria Ortega...   1455.00 Sep 18, 2020 @ 1373.00 +5.64%
Jul 13, 2020 jose fernando camacho...   1734.00 Aug 07, 2020 @ 1540.01 -11.19%
Jul 13, 2020 Iván Angulo Rodríguez   1734.00 Aug 07, 2020 @ 1540.01 -11.19%
Jul 10, 2020 EDUARDO SANCHEZ   1711.88 Jul 31, 2020 @ 1545.00 -9.75%
Jun 29, 2020 Rodolfo Patron   1717.00 Jul 24, 2020 @ 1640.00 -4.48%
May 25, 2020 Adriana Sandoval   1662.23 Jun 18, 2020 @ 1684.36 +1.33%
May 12, 2020 Jorge González...   1912.00 May 12, 2020 @ 1912.00 0.00%
May 12, 2020 Jorge González...   1912.00 May 12, 2020 @ 1912.00 0.00%
May 11, 2020 Gerardo Gomez   1911.99 Jun 05, 2020 @ 1677.00 -12.29%
May 11, 2020 STRAT CG   1895.00 Jun 05, 2020 @ 1677.00 -11.50%
May 08, 2020 jose fernando camacho...   1838.01 May 29, 2020 @ 1679.00 -8.65%
May 07, 2020 Jose Villena   1860.00 May 29, 2020 @ 1679.00 -9.73%
May 07, 2020 Ruben gerardo Jimenez...   1866.01 May 29, 2020 @ 1679.00 -10.02%
May 01, 2020 Miguel Carrillo   2012.49 May 28, 2020 @ 1676.00 -16.72%
Apr 30, 2020 Luis Angel Oliver...   1968.15 May 22, 2020 @ 1662.00 -15.56%
Apr 30, 2020 Hugo Mauricio...   1994.99 May 22, 2020 @ 1662.00 +16.69%
Apr 29, 2020 Hermann Albrecht   2000.00 Apr 30, 2020 @ 2012.49 +0.62%
Apr 23, 2020 Alejandro Campo   2049.99 May 15, 2020 @ 1835.00 -10.49%
Apr 17, 2020 Jose Reyes   1860.35 May 08, 2020 @ 1839.40 -1.13%
Apr 07, 2020 Raul Nose   1790.00 May 01, 2020 @ 2012.49 +12.43%
Mar 25, 2020 Rosa Adriana Padilla...   1749.00 Apr 17, 2020 @ 1994.89 +14.06%
Mar 17, 2020 Samuel Gualito   1669.00 Apr 10, 2020 @ 1783.00 +6.83%
Feb 28, 2020 STRAT CG   1355.00 Mar 20, 2020 @ 1778.60 +31.26%
Feb 27, 2020 STRAT CG   1444.00 Feb 28, 2020 @ 1429.07 -1.03%
Oct 29, 2018 Ricardo Aguilar   1416.01 Nov 28, 2018 @ 1170.57 -17.33%
Oct 24, 2018 Pablo De Vecchi   1388.00 Nov 23, 2018 @ 1170.57 -15.66%
Sep 03, 2018 Carlos Vazquez   1440.00 Oct 03, 2018 @ 1170.57 +18.71%
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

GILD Price Commentary

Write your thoughts about Gilead Sciences Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Oc Masai
Oc Masai Apr 27, 2021 7:54
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good job GILD. bullish move forward
Ashraf Elgendy
Ashraf Elgendy Mar 07, 2021 13:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Kite, a unit of Gilead Sciences (GILD),has announced that theFDA has granted approval for its T cell immunotherapy Yescarta (axicabtagene ciloleucel) for a certain category of adults...
RM RM
RM RM Mar 01, 2021 21:53
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up Again
Ken Laing
Ken Laing Oct 23, 2020 18:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Time to load up before the big rise coming next week
Iggy Maldon
Iggy Maldon Jul 30, 2020 20:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Classic pump n’ dump. What a shambles
RM RM
RM RM May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will reach above 95
Chili Daug
Chili Daug May 28, 2020 22:24
Saved. See Saved Items.
This comment has already been saved in your Saved Items
when? hahah
SAGAR AGARWAL
SAGAR AGARWAL May 15, 2020 14:52
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good time to accumulate.
Khizer Malik
Khizer Malik May 14, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Gilead will be supplying remdesivir to 127 countries starting next week! Also backed by big government organisations including donald trump. Good investmenr
Willy Chin
Willy Chin Apr 23, 2020 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
High chance to be trading above 90, good long stock
Viktor Veselý
Viktor Veselý Apr 12, 2020 7:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
By Deena Beasley(Reuters) - More than two-thirds of severely ill COVID-19 patients saw their condition improve after treatment with remdesivir, an experimental drug being developed by Gilead Sciences Inc., according to new data based on patient observation.The analysis, published on Friday by the New England Journal of Medicine, does not detail what other treatments the 61 hospitalized patients were given and data on eight of them were not included -- in one case because of a dosing error.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email